Macoven Pharmaceuticals Accused Of Patent Infringement

Magnolia-based Macoven Pharmaceuticals has been accused of intellectual property violations in a complaint filed with the U.S. International Trade Commission.

Pamlab, Merck & Cie, and the South Alabama Medical Science Foundation allege Macoven imported drugs from Italy that infringe on the plaintiffs’ patents. The class of drugs, known as reduced folates, is prescribed to treat high-risk pregnancy, dementia, and depression, among other medical conditions.

Jamie Underwood, a partner with the law firm of Alston & Bird, is an attorney for the complainants.

“Money damages are not available at the ITC. Instead what you get is a type of injunction or an exclusion order, typically, so that any infringing products are not coming into the U.S. market.”

This is the third legal action the complainants have taken against Macoven in the past year. The first two were law suits filed in federal courts in Texas and New York.

Calls to Macoven requesting comment for this story were not returned.


Andrew Schneider

Andrew Schneider

Politics and Government Reporter

Andrew heads Houston Public Media’s coverage of national, state, and local elections. He also reports on major policy issues before the Texas delegations in the U.S. House and Senate, as well as the Texas governorship, the state legislature, and county and city governments. Before taking up his current post, Andrew...

More Information